Emergency Departments

The article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.

This Issue Brief presents best practices and considerations for agencies hoping to develop or expand street medicine and outreach care, through in-person on-site services as well as telehealth delivery, will also be presented.

ED Visits Involving Alcohol Short Report presents the following data from January 2021-September 2023 (1) national estimates and characteristics of alcohol-related ED visits (2) demographics of alcohol-related ED visits (3) percent of ED visits related to alcohol and at least one other substance.

This NIDA web page includes information on commonly used drugs, including prescription drugs, with the potential for misuse or addiction.

This fact sheet includes a basic description of the overdose reversal medication, naloxone. It addresses who should carry it, how to recognize and overdose, and what to do if an overdose is suspected.

This report is intended to support state Medicaid agencies and payers in improving access to substance use disorder treatment, quality, and capacity, with a special focus on medication-assisted treatment for opioid use disorder.

This toolkit, designed to augment overdose prevention and reversal training, provides guidance on the role of opioid overdose reversal medications, including naloxone and nalmefene, and how to respond to an overdose.

This web page is a resource center for social media, video, print, radio, FAQs, messaging, and other marketing materials that can be used to promote the 988 Suicide & Crisis Lifeline. It is designed for states, territories, tribes, crisis centers, communities, emergency service providers, and other partners to speak with one voice.

This technical package presents strategies that can help state, local, and tribal leaders and healthcare professionals link persons living with OUD to evidence-based care.

This fact sheet provides healthcare providers and people who use drugs with an overview of fentanyl and fentanyl test strips to prevent overdose. Other harm reduction strategies are also provided.